• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疫苗接种覆盖率低的发达国家中百日咳的流行病学:意大利的经验

Epidemiology of pertussis in a developed country with low vaccination coverage: the Italian experience.

作者信息

Binkin N J, Salmaso S, Tozzi A E, Scuderi G, Greco D, Greco D

机构信息

Laboratory of Epidemiology and Biostatistics, Istituto Superiore di Sanità, Rome, Italy.

出版信息

Pediatr Infect Dis J. 1992 Aug;11(8):653-61.

PMID:1523078
Abstract

In Italy pertussis vaccination is optional. Fewer than 40% of children younger than 5 years of age are vaccinated, and pertussis remains a common childhood disease. We use data from a variety of sources to examine trends and characteristics of Italian children with pertussis and reasons behind the low vaccine coverage. Approximately 25% of Italian children have experienced clinical pertussis by their fifth birthday. The disease is most severe in those less than 1 year of age; in this group an estimated 1 in 14 cases are hospitalized and 1 in 850 die. The incidence appears to be increasing in the 1- to 4-year age group despite increased vaccination coverage. The low vaccine coverage appears to be caused by the ambivalence of the Italian pediatric community about the vaccine rather than parental concerns about vaccine safety. Legislation is being considered to make pertussis vaccination mandatory.

摘要

在意大利,百日咳疫苗接种是可选择的。5岁以下儿童中接种疫苗的不到40%,百日咳仍是一种常见的儿童疾病。我们使用来自各种来源的数据来研究意大利百日咳患儿的趋势和特征以及疫苗接种率低的原因。约25%的意大利儿童在5岁生日前经历过临床百日咳。该疾病在1岁以下儿童中最为严重;在这个年龄组中,估计每14例病例中有1例住院,每850例中有1例死亡。尽管疫苗接种率有所提高,但1至4岁年龄组的发病率似乎仍在上升。疫苗接种率低似乎是由于意大利儿科界对该疫苗态度矛盾,而非家长对疫苗安全性的担忧。目前正在考虑立法强制进行百日咳疫苗接种。

相似文献

1
Epidemiology of pertussis in a developed country with low vaccination coverage: the Italian experience.疫苗接种覆盖率低的发达国家中百日咳的流行病学:意大利的经验
Pediatr Infect Dis J. 1992 Aug;11(8):653-61.
2
Control of pertussis in the world.全球百日咳的防控
World Health Stat Q. 1992;45(2-3):238-47.
3
Impact of a pertussis booster vaccination program in adolescents and adults on the epidemiology of pertussis in Austria.奥地利青少年和成人百日咳加强免疫接种计划对百日咳流行病学的影响。
Pediatr Infect Dis J. 2007 Sep;26(9):806-10. doi: 10.1097/INF.0b013e318124a9dd.
4
How increased pertussis vaccination coverage is changing the epidemiology of pertussis in Italy.百日咳疫苗接种覆盖率的提高如何改变意大利百日咳的流行病学。
Vaccine. 2005 Nov 16;23(46-47):5299-305. doi: 10.1016/j.vaccine.2005.07.061. Epub 2005 Aug 8.
5
Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.对瑞典在3、5和12月龄接种无细胞百日咳疫苗的儿童进行长期随访表明,5至7岁时需要加强一剂疫苗。
Pediatrics. 2006 Sep;118(3):978-84. doi: 10.1542/peds.2005-2746.
6
[Pertussis in the Netherlands].[荷兰的百日咳]
Ned Tijdschr Geneeskd. 2010;154:A1383.
7
Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: analyses of 10 years of pertussis surveillance.婴儿期百日咳疫苗接种可降低百日咳发病和 1 剂和 2 剂后住院率:10 年百日咳监测分析。
Vaccine. 2012 May 2;30(21):3239-47. doi: 10.1016/j.vaccine.2011.10.089. Epub 2011 Nov 15.
8
Experiences with acellular pertussis vaccine in Japan and epidemiology of pertussis.日本无细胞百日咳疫苗的使用经验及百日咳流行病学
Tokai J Exp Clin Med. 1987 Dec;12(5-6):263-73.
9
[Monitoring of a whooping cough epidemic 1994/95 in Switzerland using the sentinel notification system. Sentinella Registry].[利用哨点通报系统对1994/95年瑞士百日咳疫情的监测。哨兵登记处]
Schweiz Med Wochenschr. 1996 Aug 24;126(34):1423-32.
10
Hospital-based active surveillance of childhood pertussis in Austria from 1996 to 2003: estimates of incidence and vaccine effectiveness of whole-cell and acellular vaccine.1996年至2003年奥地利基于医院的儿童百日咳主动监测:全细胞疫苗和无细胞疫苗的发病率及疫苗效力评估
Vaccine. 2006 Aug 14;24(33-34):5960-5. doi: 10.1016/j.vaccine.2006.05.011. Epub 2006 May 23.

引用本文的文献

1
Determinants of influenza vaccine hesitancy among pregnant women in Europe: a systematic review.影响欧洲孕妇接种流感疫苗犹豫的因素:系统综述。
Eur J Med Res. 2021 Sep 28;26(1):116. doi: 10.1186/s40001-021-00584-w.
2
Pertussis over two decades: seroepidemiological study in a large population of the Siena Province, Tuscany Region, Central Italy.二十多年来的百日咳:意大利托斯卡纳大区锡耶纳省一大部分人群的血清流行病学研究。
BMJ Open. 2019 Oct 30;9(10):e032987. doi: 10.1136/bmjopen-2019-032987.
3
Pertussis post-exposure prophylaxis among household contacts: a cost-utility analysis.
家庭接触者中百日咳暴露后预防:成本效用分析
PLoS One. 2015 Mar 6;10(3):e0119271. doi: 10.1371/journal.pone.0119271. eCollection 2015.
4
Pertussis: a review of disease epidemiology worldwide and in Italy.百日咳:全球及意大利疾病流行病学综述。
Int J Environ Res Public Health. 2012 Dec;9(12):4626-38. doi: 10.3390/ijerph9124626.
5
The distribution over time of costs and social net benefits for pertussis immunization programs.百日咳免疫计划的成本和社会净效益随时间的分布情况。
Int J Health Care Finance Econ. 2010 Mar;10(1):1-27. doi: 10.1007/s10754-009-9058-2. Epub 2009 Mar 18.
6
Assessment of humoral and cell-mediated immunity against Bordetella pertussis in adolescent, adult, and senior subjects in Italy.意大利青少年、成年人和老年人针对百日咳博德特氏菌的体液免疫和细胞介导免疫评估。
Epidemiol Infect. 2008 Nov;136(11):1576-84. doi: 10.1017/S0950268807000192. Epub 2008 Jan 16.
7
Which strategy for pertussis vaccination today?如今百日咳疫苗接种采用哪种策略?
Paediatr Drugs. 2002;4(5):299-313. doi: 10.2165/00128072-200204050-00003.
8
Pertussis complications in Germany--3 years of hospital-based surveillance during the introduction of acellular vaccines.德国百日咳并发症——无细胞疫苗引入期间的3年医院监测
Infection. 1998 Jul-Aug;26(4):227-31. doi: 10.1007/BF02962368.
9
Economic evaluation of pertussis prevention by whole-cell and acellular vaccine in Germany.德国全细胞百日咳疫苗和无细胞百日咳疫苗预防百日咳的经济学评价。
Eur J Pediatr. 1998 May;157(5):395-401. doi: 10.1007/s004310050837.
10
A cellular pertussis vaccine (Infanrix-DTPa; SB-3). A review of its immunogenicity, protective efficacy and tolerability in the prevention of Bordetella pertussis infection.一种细胞百日咳疫苗(英凡里尔-白百破疫苗;SB-3)。对其在预防百日咳博德特氏菌感染方面的免疫原性、保护效力和耐受性的综述。
Drugs. 1996 Aug;52(2):254-75. doi: 10.2165/00003495-199652020-00010.